Country Profile: Austria

Recommendations

Children:
Children aged 2 to 14 months

At-risk groups:
At-risk groups aged 2-60, including functional or anatomic asplenia; innate or acquired immune defects; cochlea implants or liquour fistula; prior to organ transplants, after stem cell transplantation, in case of nephrotic syndrome, prior to an immune suppressive therapy; chronic diseases like diseases of the hematopoietic organs; premature babies and children with weight under the 3rd percentile; children with neurological diseases; people after liquor loss, e.g. after trauma or skull surgery; celiac disease. People exposed to metal smoke (e.g. welding)​

Older adults:
All people over the age of 61

Coverage figures

Children: 96.00% (2021)

At-risk groups: 11.00%1 (2016)

Older adults: 12.00%2 (2017)

Vaccination advisory body/committee

National Vaccination Board (Nationales Impfgremium)

Visit website

 

Notes:

1 Figure taken from Ipsos Healthcare survey based on interviews with 1000 people aged 50 years and over.

2 Figure taken from Ipsos Healthcare survey based on interviews with 518 people aged 65 years and over.

 

Sources:

Children

ECDC vaccine scheduler: https://vaccine-schedule.ecdc.europa.eu/Scheduler/ByDisease?SelectedDiseaseId=25&SelectedCountryIdByDisease=18

At risk groups

ECDC vaccine scheduler: https://vaccine-schedule.ecdc.europa.eu/Scheduler/ByDisease?SelectedDiseaseId=25&SelectedCountryIdByDisease=18

At-risk groups aged 3-5 years: vaccination is recommended but not funded by the National Health system.

Older adults

ECDC vaccine scheduler: https://vaccine-schedule.ecdc.europa.eu/Scheduler/ByDisease?SelectedDiseaseId=25&SelectedCountryIdByDisease=18

Older adults aged 61 and over: vaccination is recommended but not funded by the National Health system.

Report an issue: Something doesn’t look right? Contact us